Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Phase II Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Metastatic or Recurrent Head and Neck Cancer"

NCT01264328 is registered in ClinicalTrials.gov with Grupo Español de Tratamiento de Tumores de Cabeza y Cuello as lead sponsor.

NCT NCT01264328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01264328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Phase II Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Metastatic or Recurrent Head and Neck Cancer"
Lead sponsor
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Phase
Phase 2
Overall status
Completed
Start date
March 9, 2011
Completion date
September 29, 2014
Enrollment
40 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer